Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Teva Announces Sale of PARAGARD® (intrauterine copper contraceptive) to CooperSurgical
Tuesday, September 12, 2017Teva Pharmaceutical Industries Ltd today announced it has entered into a definitive agreement under which CooperSurgical will acquire PARAGARD intrauterine copper contraceptive a product within its global Womens Health business in a billion cash tra...
HanAll Biopharma and Harbour BioMed Sign Collaboration and License Agreement to Develop Two Novel Biologic Therapies in Greater China
Tuesday, September 12, 2017HanAll Biopharma Co Ltd and Harbour BioMed announced today that they have entered into a strategic collaboration and license agreement to develop manufacture and commercialize in Greater China including Hong Kong Macau and Taiwan HanAlls two novel bi...
HitGen and Takeda Enter DNA-Encoded Library Based Drug Discovery Research Collaboration
Monday, September 11, 2017HitGen Ltd announced that the company has entered into a research collaboration with Takeda Pharmaceutical Company Limited to discover novel small molecule leads for multiple targets in Takedas therapeutic areas of interest According to the agreement...
Phosplatin Therapeutics Announces Collaboration with Pfizer and Merck KGaA, Darmstadt, Germany to Evaluate Combination of PT-112 and Avelumab in Phase I / II Studies
Monday, September 11, 2017Phosplatin Therapeutics LLC a clinical stage pharmaceutical company focused on oncology drug development announced today it has entered into a collaboration agreement with Pfizer and Merck KGaA Darmstadt Germany to evaluate PT a novel small molecule...
Project ALS and Amylyx Enter Collaboration to Test AMX0035
Friday, September 08, 2017Project ALS and Amylyx Pharmaceuticals today announced a collaboration to undertake preclinical studies with Amylyxs oral compound AMX to advance the understanding of the compounds neurobiological effects The studies to be conducted at the Project AL...
Bristol-Myers Squibb Completes Acquisition of IFM Therapeutics
Friday, September 08, 2017BristolMyers Squibb Company announced that it has completed the previously announced planned acquisition of IFM Therapeutics The transaction includes full rights to IFMs preclinical STING stimulator of interferon genes and NLRP agonist programs fo...
Alcami to Establish Active Pharmaceutical Ingredient Center of Excellence in Germantown, Wisconsin
Thursday, September 07, 2017Alcami Corporation a leading provider of custom development and manufacturing services for the pharmaceutical and biotechnology industries today announces the formation of a Center of Excellence at its worldclass active pharmaceutical ingredient API...
Immune Therapeutics, Inc. Announces Exclusive Agreement For Sale Of Lodonal In Kenya
Thursday, September 07, 2017Immune Therapeutics Inc a specialty pharmaceutical company focused on developing and commercializing Lodonal its patented affordable nontoxic therapy for the management of cancer HIV autoimmune diseases and other inflammatory conditions today announc...
Ligand Announces Top-Line Results from Phase 2 Study of LGD-6972 in Patients with Type 2 Diabetes
Wednesday, September 06, 2017Ligand Pharmaceuticals Incorporated announced positive topline results from a Phase clinical study evaluating the efficacy and safety of LGD as an adjunct to diet and exercise in subjects with type diabetes mellitus TDM inadequately controlled on m...
MEI Pharma Announces Exclusive License Agreement with Presage Biosciences
Wednesday, September 06, 2017MEI Pharma Inc an oncology company focused on the clinical development of novel therapies for cancer today announced that it has entered into a license agreement with Presage Biosciences Inc for voruciclib a clinicalstage oral and selective cyclindep...
